Oarsman Capital’s Humana HUM Stock Holding History

Oarsman Capital’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-100	Closed	-$25.4K	–	509
2024 Q4	$25.4K	Hold	100	–	–	﹤0.01%	558
2024 Q3	$31.7K	Buy	+100	New	+$35.6K	0.01%	524

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Oarsman Capital's HUM Position: Q1 2025 in Review

Oarsman Capital sold out of Humana (HUM) in Q1 2025, closing a stake of 100 shares — an estimated $25.4K sold.

Oarsman Capital first reported a position in HUM in Q3 2024 and held it in 2 quarters. The position peaked at $31.7K in Q3 2024. 903 funds tracked by Wall St. Rank hold HUM as of Q1 2025.

Oarsman Capital reported no remaining Humana position as of Q1 2025 after selling out during the quarter.
Oarsman Capital sold 100 Humana shares in Q1 2025, an estimated $25.4K.
Oarsman Capital first reported a position in Humana in Q3 2024 and held it in 2 quarters.
Oarsman Capital's Humana position peaked at $31.7K in Q3 2024.
903 funds tracked by Wall St. Rank held Humana as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.